BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6111532)

  • 1. Short-term systemic hemodynamic adaptation to beta-adrenergic inhibition with atenolol in hypertensive patients.
    Simon G; Franciosa JA; Gimenez HJ; Cohn JN
    Hypertension; 1981; 3(2):262-8. PubMed ID: 6111532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamics, biochemical and reflexive changes produced by atenolol in hypertension.
    Dreslinski GR; Messerli FH; Dunn FG; Suarez DH; Reisin E; Frohlich ED
    Circulation; 1982 Jun; 65(7):1365-8. PubMed ID: 6122514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Haemodynamic response to antihypertensive treatment with atenolol in patients with hypertension (author's transl].
    Zilcher H; Glogar D; Uhlir H; Leisch F; Niederberger M; Steinbach K
    Wien Klin Wochenschr; 1978 Sep; 90(16):611-6. PubMed ID: 695651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of celiprolol in essential hypertension.
    Frohlich ED; Ketelhut R; Kaesser UR; Losem CJ; Messerli FH
    Am J Cardiol; 1991 Aug; 68(5):509-14. PubMed ID: 1678580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH; Man in't Veld AJ; Boomsma F; Fischberg DJ; Molinoff PB; Schalekamp MA
    Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic consequences of long-term beta-blocker therapy: a 5-year follow-up study of atenolol.
    Lund-Johansen P
    J Cardiovasc Pharmacol; 1979; 1(5):487-95. PubMed ID: 94405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effect of atenolol on hemodynamic, plasma renin activity and plasma aldosterone concentration in the once daily oral administration.
    Sasaki Y; Arakawa K
    Jpn Circ J; 1984 Sep; 48(9):988-93. PubMed ID: 6384568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive effects of tertatolol. A comparative study versus atenolol.
    Mota JC; Carrageta MD; Felix S; Nunes AM; Jobbé-Duval M
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):284S-288S. PubMed ID: 2573377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of atenolol in labile hypertension.
    González-Gómez A; García-Barreto D; Fránquiz JM
    Arch Int Pharmacodyn Ther; 1983 Feb; 261(2):260-7. PubMed ID: 6838285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic and hormonal adaptations to beta-adrenoceptor blockade. A 24-hour study of acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH; Man in 't Veld AJ; van Eck HJ; Boomsma F; Schalekamp MA
    Circulation; 1988 Oct; 78(4):957-68. PubMed ID: 3048776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and long-term effects of nitrendipine on resting and exercise hemodynamics in essential hypertension.
    Nannan ME; Melin JA; Vanbutsele RJ; Lavenne F; Detry JM
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1043-8. PubMed ID: 6085364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
    Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
    Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the cardiac and hemodynamic effects of lisinopril and atenolol in patients with hypertension: therapeutic implications.
    Zusman RM; Christensen DM; Higgins J; Boucher CA
    J Cardiovasc Pharmacol; 1992 Aug; 20(2):216-22. PubMed ID: 1381012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension.
    Lund-Johansen P
    Br J Clin Pharmacol; 1976 Jun; 3(3):445-51. PubMed ID: 973971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of atenolol, a new cardioselective beta-blocker, on plasma renin activity in treatment of hypertension.
    Balansard P; Chabrillat Y; Paulin R; Libes M; Gérard R
    Acta Cardiol; 1977; 32(4):229-43. PubMed ID: 304291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modest antihypertensive effect of epanolol, a beta 1-selective receptor blocker with beta 1 agonist activity: an acute and long-term hemodynamic study at rest and during exercise and double crossover comparison with atenolol on ambulatory blood pressure.
    Omvik P; Lund-Johansen P; Haugland H
    Cardiovasc Drugs Ther; 1993 Feb; 7(1):125-32. PubMed ID: 8097925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of atenolol on left ventricular function in hypertensive patients.
    Ibrahim MM; Madkour MA; Mossallam R
    Circulation; 1980 Nov; 62(5):1036-45. PubMed ID: 7418154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cardiac factors in the initial hypotensive action by beta-adrenoreceptor blocking agents.
    Colfer HT; Cottier C; Sanchez R; Julius S
    Hypertension; 1984; 6(2 Pt 1):145-51. PubMed ID: 6144632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic adjustments in hypertensive patients developing circulatory congestion during beta-adrenergic blockade.
    Reybrouck T; Amery A; Billiet L; Fagard R
    Cardiology; 1979; 64(2):97-109. PubMed ID: 436128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of beta-adrenergic blocking agents on the blood pressure, plasma renin activity and hemodynamics of hypertensive patients.
    Matsunaga M; Hara A; Ogino K; Motohara S; Saito M
    Jpn Heart J; 1977 Jan; 18(1):24-30. PubMed ID: 15142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.